@misc{indiciae811af7a7a806,
  title = {BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor},
  author = {Fiskus, W. C. and Piel, J. and Collins, M. and Hentemann, M. and Cuglievan, B. and Mill, C. P. and Birdwell, C. E. and Das, K. and Davis, J. A. and Hou, H. and Jain, A. C. and Malovannaya, A. and Kadia, T. M. and Daver, N. and Sasaki, K. and Takahashi, K. and Hammond, D. and Reville, P. K. and Wang, J. and Loghavi, S. and Sen, R. and Ruan, X. and Su, X. and Flores, L. B. and DiNardo, C. D. and Bhalla, K. N.},
  year = {2023},
  doi = {10.1101/2023.09.28.560054},
  url = {https://www.biorxiv.org/content/10.1101/2023.09.28.560054v1},
  note = {Source identifier: 10.1101/2023.09.28.560054}
}